Insights on the Recombinant DNA Technology Global Market to 2027 - Featuring Amgen, Bamboo Therapeutics and Biocon Among Others

DUBLIN, May 13, 2021 /PRNewswire/ -- The "Recombinant DNA Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at a CAGR of 4.7% over the period 2020-2027.

Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $179.7 Million, While China is Forecast to Grow at 4.4% CAGR

The Recombinant DNA Technology market in the U.S. is estimated at US$179.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.5 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 32 Featured):

• Amgen Inc
• Bamboo Therapeutics, Inc.
• Biocon
• Biogen
• Chiron Corporation
• Cibus
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Genentech, Inc
• GenScript
• GlaxoSmithKline plc.
• Horizon Discovery Group plc
• Merck KGaA
• Monsanto Company
• New England Biolabs
• Novartis AG
• Novo Nordisk A/S
• Nucelis
• Pfizer Inc.
• Profacgen
• Sanofi
• Syngene

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES
• CANADA
• JAPAN
• CHINA
• EUROPE
• FRANCE
• GERMANY
• ITALY
• UNITED KINGDOM
• REST OF EUROPE
• ASIA-PACIFIC
• REST OF WORLD

IV. COMPETITION

• Total Companies Profiled: 32

For more information about this report visit https://www.researchandmarkets.com/r/epifxz

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com